| INNOCAN PHARMA CORP. |
| Kanada |
| Gesundheit |
| CA45783P5085 / A41FTP |
| IP40 (Frankfurt) |
| FRA:IP40, ETR:IP40, IP40:GR |
| - |
| https://innocanpharma.com.. |
|
InnoCan Pharma Corporation, a pharmaceutical techn..
>Volltext.. |
| 44.28 Mio. EUR |
| 41.35 Mio. EUR |
| 25.43 Mio. EUR |
| 0.31 Mio. EUR |
| -1.4 Mio. EUR |
| -0.31 EUR |
| 1.21 Mio. EUR |
| 6.32 Mio. EUR |
| -0.37 Mio. EUR |
| 2.48 |
| 11.02% |
| 65.48% |
| - |
| - |
| - |
| - |
| INNOCAN |
| 25.10.25 |
|
||||
|
||||
|
||||
|
||||
|